Lv11
16 积分 2026-09-17 加入
P198 Tezepelumab reduces OCS use and improves sino-nasal symptoms in OCS-dependent patients with severe asthma and comorbid chronic rhinosinusitis (overall and with nasal polyps): results from the phase 3b WAYFINDER study
1小时前
求助中
Pocket guide: biologics in upper and lower airways in adults
1小时前
已完结
Risk of Respiratory Tract Infections With Asthma Biologics
3天前
已完结
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial
6天前
已完结
Surgery and/or biologics in chronic rhinosinusitis with nasal polyps: EUFOREA/EPOS consensus paper
10天前
已关闭
Benralizumab for eosinophilic granulomatosis with polyangiitis and subclinical cardiac involvement: A fertility-preserving case report
16天前
已完结
Benralizumab: from tissue distribution to eosinophilic cytotoxicity up to potential immunoregulation
17天前
已完结
Surgery and/or biologics in chronic rhinosinusitis with nasal polyps: EUFOREA/EPOS consensus paper
17天前
已关闭
Clinical Efficacy of Tezepelumab in Moderate-to-Severe Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review of Randomized Controlled Trials
20天前
已完结
The dual role of recombinant IL-33 in acute liver failure: hepatoprotection versus lethal systemic inflammation
27天前
已完结
皖公网安备34019202002308
